These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. TceSR two-component regulatory system of Brucella melitensis 16M is involved in invasion, intracellular survival and regulated cytotoxicity for macrophages. Li Z; Fu Q; Wang Z; Li T; Zhang H; Guo F; Wang Y; Zhang J; Chen C Lett Appl Microbiol; 2015 Jun; 60(6):565-71. PubMed ID: 25721466 [TBL] [Abstract][Full Text] [Related]
4. Inhibition of in vitro immunoglobulin synthesis by Brucella melitensis. Montag T; Tietz HJ; Liebenthal C; Lorf T; Mann W; Mehl M Tokai J Exp Clin Med; 1986; 11 Suppl():39-42. PubMed ID: 3502547 [No Abstract] [Full Text] [Related]
5. [Immunization of ewes against experimental Brucella melitensis infection: comparison of eleven vaccines]. Gaumont R; Trap D; Gayot G; Pierre F; Dhennin L Dev Biol Stand; 1976; 31():377-86. PubMed ID: 944151 [TBL] [Abstract][Full Text] [Related]
6. [Sensitivity and adaptation of various Brucella species to acid shock]. Kulakov IuK; Zheludkov MM; Seliutina DF; Skavronskaia AG Mol Gen Mikrobiol Virusol; 1999; (3):8-12. PubMed ID: 10495976 [TBL] [Abstract][Full Text] [Related]
7. Metabolic characterization of Brucella strains that show conflicting identity by biochemical and serological methods. MEYER ME; MORGAN WJ Bull World Health Organ; 1962; 26(6):823-7. PubMed ID: 14473150 [TBL] [Abstract][Full Text] [Related]
8. SiRNA screens using Drosophila cells to identify host factors required for infection. Pandey A; Ding SL; Ficht TA; de Figueiredo P Methods Mol Biol; 2014; 1197():229-44. PubMed ID: 25172284 [TBL] [Abstract][Full Text] [Related]
9. IMMUNIZATION AGAINST BRUCELLA INFECTION. 10. THE RELATIVE IMMUNOGENICITY OF BRUCELLA ABORTUS STRAIN 19-BA AND BRUCELLA MELITENSIS STRAIN REV I IN CYNOMOLGUS PHILIPPINENSIS. ELBERG SS; FAUNCE WK Bull World Health Organ; 1964; 30(5):693-9. PubMed ID: 14196815 [TBL] [Abstract][Full Text] [Related]
14. Brucella pathogenesis, genes identified from random large-scale screens. Delrue RM; Lestrate P; Tibor A; Letesson JJ; De Bolle X FEMS Microbiol Lett; 2004 Feb; 231(1):1-12. PubMed ID: 14979322 [TBL] [Abstract][Full Text] [Related]
15. The immunological properties of Brucella ribosomal preparations. Corbel MJ Dev Biol Stand; 1976; 31():115-22. PubMed ID: 816681 [TBL] [Abstract][Full Text] [Related]
16. [A comparative study of the intensity of immunity created by vaccinal strains of Br. abortus 19, Br. melitensis Rev 1 and Br. suis 61 following their simultaneous and separate administration]. Kozlov MP; Zamakhaeva EI Zh Mikrobiol Epidemiol Immunobiol; 1969 Aug; 46(8):25-31. PubMed ID: 4982998 [No Abstract] [Full Text] [Related]
17. Phage-typing of brucella strains collected in Italy during 1982-83. Gargani G Arch Inst Pasteur Tunis; 1983 Dec; 60(3-4):327-36. PubMed ID: 6442850 [TBL] [Abstract][Full Text] [Related]
18. The use of gel diffusion precipitin plates in the study of Brucella. BRUCE W; JONES LM Bull World Health Organ; 1958; 19(1):187-96. PubMed ID: 13585068 [TBL] [Abstract][Full Text] [Related]
19. Identification of Cross-Protective Potential Antigens against Pathogenic Hisham Y; Ashhab Y J Immunol Res; 2018; 2018():1474517. PubMed ID: 30622973 [TBL] [Abstract][Full Text] [Related]
20. Hyaluronidase in human semen and sperm suspensions subjected to temperature shock and to freezing. Ackerman DR J Reprod Fertil; 1970 Dec; 23(3):521-3. PubMed ID: 5492033 [No Abstract] [Full Text] [Related] [Next] [New Search]